A three page information sheet to help healthcare consumers understand the MedicineInsight program.
Available in English, easy English, Arabic, Chinese (simplified), Chinese (traditional), Croatian, Farsi, Greek, Italian, Korean, Macedonian, Spanish, Turkish, and Vietnamese.
Each practice participating in MedicineInsight must display the printed MedicineInsight poster in their waiting room or display this digital version on practice media devices.
All practices participating in MedicineInsight must display this poster in their waiting room and provide patients with an information sheet if they request more information. A version of this poster in landscape orientation is also available for digital display screens.
An independent Privacy Impact Assessment (PIA) was undertaken by NPS MedicineWise, the former custodians of MedicineInsight, to evaluate the program's approach to privacy, security and confidentiality. Its findings are presented in this report.
The General Practice Insights Reports provide an overview of the care provided in general practice. These reports have been paused until the program returns to full operational status. The 2016-17 report was developed by the former custodians of MedicineInsight, NPS MedicineWise.
The General Practice Insights Reports provide an overview of the care provided in general practice. These reports have been paused until the program returns to full operational status. The 2018-19 report was developed by the former custodians of MedicineInsight, NPS MedicineWise.
The General Practice Insights Reports provide an overview of the care provided in general practice. These reports have been paused until the program returns to full operational status. The 2020-21 report was developed by the former custodians of MedicineInsight, NPS MedicineWise.
The National Consensus Statement: Essential elements for safe and high‑quality end‑of‑life care provides healthcare services with a best practice approach to caring for people who are approaching the end of their life. There are nine guiding principles that define safe and high‑quality end‑of‑life care.
Read the latest edition of Person-centred Care Insights. Discover a rich array of resources empowering person-centred care: our robust Resource Hub, innovative initiatives, new support materials, ongoing research projects, and the latest expert publications.
The Australian Group on Antimicrobial Resistance (AGAR) annually publishes data on antimicrobial resistance (AMR) and epidemiologic and genetic patterns in bloodstream infections in Australia, relating to three main organisms: enterococcal species, Staphylococcus aureus and gram-negative bacteria.
A public consultation on the Module was conducted between October 2022 and February 2023. This document outlines the public consultation process and summarises participation and the feedback received.
Findings from the consultation process were used to inform amendments to the Module and will support the development of implementation resources.
This fact sheet explains some actions for consumers and/or their carers take to help keep safe while using insulin. Insulins are available in different strengths and formulations or presentations with medicine names that look and sound similar. Consumers need to ‘stop, think and check’ that they have the right brand of insulin in the right strength before administering.
This factsheet highlights best practise dispensing to support safe and quality use of insulin, within the context of active ingredient prescribing. Safe and quality use of insulins requires clear information transfer from initial prescribing to the dispensing label, to ensure safe use by consumers and/or their carers.
The Commission has developed the National Safety and Quality Cosmetic Surgery Standards to ensure patients receive safe, high-quality care in facilities where cosmetic surgery is performed.
The Cosmetic Surgery Standards were released on 14 December 2023.
Charlotte Jerrim from Canberra was 19 years old when she was sold a dream of enhancing her body with a breast augmentation procedure. Unfortunately, this dream did not match the reality.
In this case study, Charlotte shares her experience with cosmetic surgery, as the Commission released national standards for services that perform cosmetic surgery.
The National Safety and Quality Cosmetic Surgery Standards were launched on 14 December 2023. The standards aim to protect the public from harm and improve the quality of cosmetic surgery in Australia.
This A4 infographic showcases key data insights into cosmetic surgery in Australia.
Australians choosing to have cosmetic surgery will be better protected by new standards introduced today. The National Safety and Quality Cosmetic Surgery Standards will improve patient safety in facilities where cosmetic surgery is performed.
This fact sheet has been developed at the request of the Department of Health and Aged Care. It aims to assist health service organisations (HSOs) and clinicians understand and manage the safety issues related to a worldwide shortage, and disruption to the supply of benzathine benzylpenicillin (Bicillin L-A) in Australia.
This fact sheet is for use during a period of shortage only.
This resource provides general information for health professionals working in Aboriginal Medical Services or Aboriginal Community Controlled Health Organisations. There is also a fact sheet for consumers.
A draft framework of actions for health service organisations to use achieve environmental sustainability and climate resilience for their health services.
AURA 2023: Fifth Australian Report on Antimicrobial Use and Resistance in Human Health is being released on 16 November 2023, highlighting data trends and analyses across acute and community care settings.
This Key Findings summary features the most compelling data findings from AURA 2023, with excerpts taken from the report for easy reference.
Australians are unwittingly being exposed to increased risk of harm from taking antibiotics, when often these medicines are used to treat common infections where they will have no or little benefit, according to the Australian Commission on Safety and Quality in Health Care.
This resource outlines what antimicrobial resistance (AMR) is, and how we need to limit our use of antimicrobials – such as antibiotics, antivirals, antifungals and antiparasitics – to reduce the risk of drug-resistant infections and impact of AMR.
